Pay-For-Delay Suits Get New Life Following High Court Ruling
The U.S. Supreme Court's ruling Monday allowing antitrust challenges to reverse payment patent settlements breathed new life into lawsuits targeting pharmaceutical companies over pay-for-delay deals, with most cases likely to survive...To view the full article, register now.
Already a subscriber? Click here to view full article